| Dr Kyle Green, PHARMD | |
|
906 Sw Regional Airport Blvd, Bentonville, AR 72713-7364 | |
| (479) 268-7678 | |
| Not Available |
| Full Name | Dr Kyle Green |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 906 Sw Regional Airport Blvd, Bentonville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639771413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | PD12141 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle Green, PHARMD 906 Sw Regional Airport Blvd, Bentonville, AR 72713-7364 Ph: (479) 268-7678 | Dr Kyle Green, PHARMD 906 Sw Regional Airport Blvd, Bentonville, AR 72713-7364 Ph: (479) 268-7678 |
News Archive
The biomedical research program of Weill Cornell Medical College in Qatar has made significant progress in its dual goals of advancing basic science and building a sustainable research community in Qatar since it was launched less than a year and a half ago.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
Top stroke experts have issued new guidance to ensure stroke patients receive safe, timely care while preventing the transmission of COVID-19.
› Verified 8 days ago
Michael Fertig, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2730 Sw Livingston Sq, Bentonville, AR 72713 Phone: 214-578-3685 | |
Jessie Joann Kruse, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1204 Se 28th St Ste 2, Bentonville, AR 72712 Phone: 888-414-5805 Fax: 855-422-2400 | |
Darren Keith Townzen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 Sw 8th St, Bentonville, AR 72712 Phone: 479-381-6136 | |
Rane Dearing, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Se 14th St, Bentonville, AR 72712 Phone: 479-621-6470 Fax: 479-621-6461 | |
Pierce Wyland Skersick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2805 Mid Cities Dr, Bentonville, AR 72712 Phone: 479-271-7634 | |
Tatum Bishop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Se 14th St, Bentonville, AR 72712 Phone: 479-621-9470 | |
Mr. Kirk Eugene Milam, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 316 Nw Lasalle Dr, Bentonville, AR 72712 Phone: 479-271-9007 |